Treatment of Parkinson’s disease using focused ultrasound with GDNF retrovirus-loaded microbubbles to open the blood–brain barrier

• Published in: Open Chemistry 2020-08, Vol.18 (1), p.882-889
• Main Authors: Wang, Feng, Li, Nana, Hou, Ruanling, Wang, Lu, Zhang, Libin, Li, Chenzhang, Zhang, Yu, Yin, Yaling, Chang, Liansheng, Cheng, Yuan, Wang, Yongling, Lu, Jianping
• Format: Article
• Language: English
• Subjects: cationic microbubble; GDNF; Parkinson’s disease; retrovirus
• ISSN: 2391-5420; 2391-5420
• DOI: 10.1515/chem-2020-0142

This study aims to prepare ultrasound-targeted glial cell-derived neurotrophic factor (GDNF) retrovirus-loaded microbubbles (M pLXSN-GDNF) to verify the properties of the microbubbles and to study the therapeutic effect of the GDNF retrovirus-loaded microbubbles combined with ultrasound (U) to open the blood–brain barrier (BBB) in a Parkinson’s disease (PD) model in rats, allowing the retrovirus to pass through the BBB and transfect neurons in the of the midbrain, thereby increasing the expression of GDNF. The results of western blot analysis revealed significant differences between U + MpLXSN-EGFP, U + M + pLXSN-GDNF, and M pLXSN-GDNF ( < 0.05) groups. After 8 weeks of treatment, the evaluation of the effect of increased GDNF expression on behavioral deficits in PD model rats was conducted. The rotation symptom was significantly improved in the U + MpLXSN-GDNF group, and the difference before and after treatment was significant ( < 0.05). Also, the content of dopamine and the number of tyrosine hydroxylase-positive (dopaminergic) neurons were found to be higher in the brain of PD rats in the U + M pLXSN-GDNF group than in the control groups. Ultrasound combined with GDNF retrovirus-loaded microbubbles can enhance the transfection efficiency of neurons and highly express the exogenous gene to play a therapeutic role in PD model rats.